大うつ病における患者報告によるブレクスピプラゾルの有効性は,フェーズ4のオープン・ラベル介入試験において
François Therrien1, Pratap Chokka2,3, Jeffrey Habert4
1Otsuka Canada Pharmaceutical Inc., Saint-Laurent, Quebec, Canada.
Current medical research and opinion
|September 6, 2025
まとめ
ブレックスピプラゾルの併用は,患者の報告したうつ病の重症度および8週間の主要なうつ病 (MDD) に関する関与を有意に改善しました. 患者さんの日記
科学分野:
- 精神科
- 臨床心理学
- 薬理学について
背景:
- 重度のうつ病 (MDD) は患者の健康状態と日常生活に影響を及ぼします.
- 標準的な抗うつ薬に対する反応が不十分な患者には,補助的な治療が不可欠です.
- 患者によって報告されたアウトカムは,治療の有効性と経験に関する貴重な洞察を提供します.
研究 の 目的:
- ENGAGE研究からの日記データを用いて,添加的なブレクスピプラゾールに関する患者の見解を分析する.
- 鬱病の重症度と人生への関与に対するブレキスピラゾールの効果を評価する.
- 臨床試験における"今日の言葉"の発展と有用性を説明する.
主な方法:
- 8週間のオープンなENGAGE研究 (NCT04830215) の患者日記データ分析
- 患者全体の印象 - 重症度 (PGI-S) と改善度 (PGI-I) を含む.
- 患者さんの日常的な感情を捉えるために"その日の言葉"の活動を活用しました.
主要な成果:
- PGI- Sスコアがベースラインから第8週まで有意に改善 (p < 0. 001)
- 患者はPGI- Iで"わずかな改善"から"非常に多くの改善"を報告した.
- ポジティブ/ニュートラルワードの割合が増加し,ネガティブワードの割合が減少しました.
結論:
- 患者によって報告されたうつ症状の早期および持続的な改善が示されました.
- 患者からの報告は,ブレクスピプラゾールの有効性を確認しています.
- "その日の言葉"は 臨床試験における患者体験を 評価するための 価値ある 定性的なツールです
関連する概念動画
Antidepressant Drugs: MAOIs and Other Agents
337
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
337
Drugs for Treatment of Constipation-Predominant IBS
322
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
322
Interpersonal Psychotherapy
97
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
97
Dipeptidyl Peptidase 4 Inhibitors
249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249
Psychosis: Goals of Pharmacotherapy
208
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208


